发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| England | 519 |
| USA | 422 |
| CHINA MAINLAND | 147 |
| GERMANY (FED REP GER) | 147 |
| Scotland | 135 |
| Italy | 128 |
| France | 122 |
| Australia | 108 |
| Japan | 103 |
| Canada | 86 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| UNIVERSITY OF LONDON | 202 |
| UNIVERSITY OF OXFORD | 100 |
| HARVARD UNIVERSITY | 88 |
| ROYAL MARSDEN NHS FOUNDATION TRUST | 78 |
| UNIVERSITY OF CAMBRIDGE | 71 |
| UNIVERSITY OF TEXAS SYSTEM | 69 |
| UNICANCER | 64 |
| CANCER RESEARCH UK | 57 |
| UNIVERSITY OF MANCHESTER | 57 |
| INSTITUT NATIONAL DE LA SANTE ET DE LA ... | 56 |
文章引用情况
1
Paracrine roles of cellular senescence in promoting tumourigenesis2
A systematic review and quality assessment of individualised breast cancer risk prediction models3
A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours4
Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE- 0065
Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma6
Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma7
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours8
A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients9
Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer10
Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer